DeSantis Robert - Apr 21, 2023 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Role
EVP & Chief Product Officer
Signature
By: Donna Spinola For: DeSantis, Robert
Stock symbol
ISRG
Transactions as of
Apr 21, 2023
Transactions value $
-$1,161,212
Form type
4
Date filed
4/24/2023, 06:10 PM
Previous filing
Mar 1, 2023
Next filing
May 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISRG Common Stock Options Exercise $536K +2.18K +23.17% $245.60 11.6K Apr 21, 2023 Direct F1
transaction ISRG Common Stock Sale -$651K -2.18K -18.81% $297.92 9.43K Apr 21, 2023 Direct F1, F2
transaction ISRG Common Stock Options Exercise $263K +1.09K +11.52% $242.34 10.5K Apr 21, 2023 Direct F1
transaction ISRG Common Stock Sale -$324K -1.09K -10.33% $297.92 9.43K Apr 21, 2023 Direct F1, F2
transaction ISRG Common Stock Options Exercise $49.1K +273 +2.9% $179.70 9.7K Apr 21, 2023 Direct F1
transaction ISRG Common Stock Sale -$81.4K -273 -2.81% $298.00 9.43K Apr 21, 2023 Direct F1, F3
transaction ISRG Common Stock Options Exercise $48.6K +273 +2.9% $177.99 9.7K Apr 21, 2023 Direct F1
transaction ISRG Common Stock Sale -$81.4K -273 -2.81% $298.00 9.43K Apr 21, 2023 Direct F1, F3
transaction ISRG Common Stock Options Exercise $511K +2.44K +25.92% $208.90 11.9K Apr 21, 2023 Direct F1
transaction ISRG Common Stock Sale -$728K -2.44K -20.59% $297.93 9.43K Apr 21, 2023 Direct F1, F4
transaction ISRG Common Stock Sale -$356K -1.2K -12.69% $297.91 8.23K Apr 21, 2023 Direct F1, F5
transaction ISRG Common Stock Sale -$348K -1.17K -14.18% $297.90 7.07K Apr 21, 2023 Direct F1, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -273 -21.51% $0.00 996 Apr 21, 2023 Common Stock 273 $177.99 Direct F1, F7
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -273 -18.84% $0.00 1.18K Apr 21, 2023 Common Stock 273 $179.70 Direct F1, F8
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -2.44K -27.09% $0.00 6.58K Apr 21, 2023 Common Stock 2.44K $208.90 Direct F1, F9
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -1.09K -52.16% $0.00 996 Apr 21, 2023 Common Stock 1.09K $242.34 Direct F1, F9
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -2.18K -32.36% $0.00 4.57K Apr 21, 2023 Common Stock 2.18K $245.60 Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 21, 2023.
F2 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.55 to $299.16 as follows: 656 shares sold at $296.55 to $297.55; 1.979 shares sold at $297.56 to $298.53; and 635 shares sold at $298.62 to $299.16. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.61 to $299.31 as follows: 116 shares sold at $296.61 to $297.00; 370 shares sold at $297.78 to $298.74; and 60 shares sold at $298.99 to $299.31. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.52 to $299.30 as follows: 612 shares sold at $296.52 to $297.52; 1.413 shares sold at $297.57 to $298.50; and 419 shares sold at $298.63 to $299.30. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F5 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.59 to $299.27 as follows: 271 shares sold at $296.59 to $297.41; 725 shares sold at $297.66 to $298.62; and 200 shares sold at $298.68 to $299.27. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F6 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.39 to $299.22 as follows: 216 shares sold at $296.39 to $297.12; 705 shares sold at $297.42 to $298.41; and 246 shares sold at $298.50 to $299.22. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F7 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.
F8 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The grant vests 25% on the first anniversary of the date of grant and monthly thereafter, over a four year period of time.
F9 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.